Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

India-Made AIDS Vaccine Passes Initial Trials

This article was originally published in PharmAsia News

Executive Summary

An AIDS vaccine developed in India has passed Phase I trials, according to agencies involved. The candidate drug, TBC-M4, was shown to be 100 percent effective in boosting the immune response in humans to AIDS. Three groups, the Indian Council of Medical Research, the National AIDS Control Organisation and the International AIDS Vaccine Initiative are involved in the trials. The drug is based on modified vaccine Ankara virus, also being test by Bavarian Nordic as a smallpox vaccine. (Click here for more
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC069304

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel